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Abstract
Background: Despite strong evidence linking infections to the pathogenesis of bronchopulmonary dysplasia (BPD),
limitations of bacterial culture methods have precluded systematic studies of airway organisms relative to disease
outcomes. Application of molecular bacterial identification strategies may provide new insight into the role of bacterial
acquisition in the airways of preterm infants at risk for BPD.
Methods: Serial (within 72 hours, 7, 14, and 21 days of life) tracheal aspirate samples were collected from 10 preterm infants
with gestational age #34 weeks at birth, and birth weight of 500–1250 g who required mechanical ventilation for at least
21 days. Samples were analyzed by quantitative real time PCR assays for total bacterial load and by pyrosequencing for
bacterial identification.
Results: Subjects were diagnosed with mild (1), moderate (3), or severe (5) BPD. One patient died prior to determination of
disease severity. 107,487 sequences were analyzed, with mean of 3,359 (range 1,724–4,915) per sample. 2 of 10 samples
collected ,72 hours of life contained adequate bacterial DNA for successful sequence analysis, one of which was from a
subject exposed to chorioamnionitis. All other samples exhibited bacterial loads .70copies/reaction. 72 organisms were
observed in total. Seven organisms represented the dominant organism (.50% of total sequences) in 31/32 samples with
positive sequences. A dominant organism represented.90% of total sequences in 13 samples. Staphylococcus,
Ureaplasmaparvum,a n dUreaplasmaurealyticum were the most frequently identified dominant organisms, but
Pseudomonas, Enterococcus, and Escherichia were also identified.
Conclusions: Early bacterial colonization with diverse species occursafter the first 3 days of life in the airways of intubated
preterm infants, and can be characterized by bacterial load and marked species diversity. Molecular identification of bacteria
in the lower airways of preterm infants has the potential to yield further insight into the pathogenesis of BPD.
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Introduction
Bronchopulmonary dysplasia (BPD) was initially attributed to
mechanical ventilation and oxygen induced lung injury in infants
born preterm, as first described by Northway and colleagues in
1967 [1]. Inflammation of the developing lung from these
interventions and other causes is a predominate theory underlying
thepathogenesisof BPD [2,3]. Both prenatal and postnatal sources
of inflammation, including infection, may directly disrupt lung
growth [4] and predispose infants to BPD [5,6]. Because fetal
development takes place in a normally bacteria-free environment
[7], premature exposure and colonization of the neonatal
respiratory tract by bacteria may impact the neonatal immune
response, increase the risk for early and late infections, and
contribute to the subsequent development of BPD. Recent studies
have shown that airway colonization with specific organisms
during the neonatal period was associated with persistent wheeze
in childhood [8], suggesting that early specific bacterial exposure
and/or the host response contribute to future disease. Yet, little is
known about the timing of bacterial exposure and acquisition in
the airways of preterm infants, mechanisms that promote or
impede colonization of specific organisms, or the inflammatory
responses to colonizing bacteria in relation to injury to the
developing lung.
Recently developed molecular methods have suggested that the
lungs of healthy older children and adults are rich with microbes,
which has led to a new understanding of airway colonization and
has challenged the traditional theory that human lower airways
are sterile [9,10]. These methods further suggest that traditional
culture methods are not adequate to investigate the contribution of
microbial communities to disease. In addition to common
bacterial organisms that can be readily cultured, there has been
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bacteria, such as Ureaplasma, Mycoplasma, and Chlamydia, as causes
of perinatal infection that may increase the risk for the subsequent
development of BPD [11,12,13,14]. Thus, traditional culture
methods are likely not sensitive enough to provide meaningful
information on many potential pathological organisms that can
affect outcomes in preterm neonates. Culture-independent
molecular techniques offer the opportunity to identify the full
spectrum of bacteria in biological samples, and these methods may
provide new insight into the role of bacterial acquisition in the
respiratory tract of newborn preterm infants and the development
of BPD. Molecular bacterial identification methods can detail the
total bacterial load in a sample, the diversity of bacteria present,
and relative abundance of specific bacteria based on the relative
proportion of sequences in a sample.
Thus, we hypothesized that early colonization with diverse
microbial agents occurs early after birth in ventilated preterm
infants, and that application of molecular bacterial identification
strategies to serial airway samples can define changes in the
microbiome in infants at risk for chronic lung disease. In order to
investigate the airway microbiome in patients at high risk for BPD,
we performed molecular identification of bacteria in serial tracheal
aspirate samples from intubated preterm infants by isolating rRNA
genes harvested by PCR to determine the composition and the
timing of acquisition of bacterial communities in the lower
airways. We compared these results to those obtained by clinically
indicated standard laboratory cultures and described the timing of
antibiotic administration in relation to the identification of airway
bacterial communities.
Methods
Study Population
All data and specimens were obtained as part of a prospective
observational research protocol, approved by the Colorado
Multiple Institutional Review Board. Written informed consent
was received from the parents/guardians of all participants. Assent
was not obtained because all participants were infants. Criteria for
enrollment included a gestational ageof 34 weeks or less, birth
within the previous 72 hours, and a birth weight of 500 to 1250 g.
To be included in this study analysis, infants also needed to be
intubated at enrollment and remain intubated for at least 21 days
with successful collection of tracheal aspirate samples at each of 4
times points (within 72 hours of birth, and 7, 14, and 21 days of
life). Exclusion criteria werelethal congenital anomalies, complex
congenital heart disease (includingan atrial septal defect larger
than 1 cm and a ventricular septaldefect larger than 2 mm), or
anticipated death prior to hospital discharge. Maternal medical
history including complications of pregnancy and birth, and
subject data, including clinically obtained respiratory tract cultures
and antibiotic administration from the NICU course were
collected as part of the prospective study. BPD status was assessed
at 36 weeks post conceptual age via head hood oxygen reduction
test as previously described [15], anddisease severity categories-
were adjusted for altitude in Denver, Colorado (1600 m).
Specimen Collection and processing
Tracheal aspirates were collected by instillation of 0.5 mlof
sterile 0.9% saline (without preservative) via the endotracheal tube
(ETT) and suction applied to a sterile catheter inserted to 0.5 cm
below the tip of the ETTas the catheter was slowly withdrawn.
The suction catheter was cleared of retained secretions by
aspirating an additional 1 ml of the sterile saline. Specimens were
immediately spun at 2506 g for 20 minutes at uC. The
supernatant was removed and the remaining pellet was resus-
pended with 0.2 mlnormal saline and stored at 270uC.
DNA Extraction, PCR and Sequencing
DNA was prepared from each sample using the Qiagen EZ1
Advanced platform. 200 ml of clinical sample was extracted using
the bacterial card and tissue kit per manufacturer’s instructions.
Table 1. Patient Characteristics.
Patient
1 234 5 678 9 1 0
Gender Male Male Female Female Female Male Male Female Female Male
Race NHB NHB NHW HW HW HW NHW NHW HW NHW
Gestational age (PMA, weeks) 26 27 26 24 25 25 26 26 24 25
Birth weight (grams) 776 835 852 605 1000 700 945 770 669 905
APGAR 1 min. 3 113 1 163 3 5
APGAR 5 min. 8 416 5 157 3 7
BPD Severity Expired Severe Mild Severe Mild Severe Mod. Severe Mod. Severe
Mechanical Ventilation Days 39 42 49 59 22 33 44 46 27 33
CPAP days 0 26 0 15 14 17 11 12 6 21
Oxygen days (including
positive pressure support)
39 131 98 120 83 112 112 153 126 128
Discharged on oxygen Yes No No Yes Yes No Yes Yes Yes Yes
NICU days 39* 142 116 120 83 128 112 153 126 128
Gestational age at time
of discharge, weeks
31.6* 47.3 42.6 41.1 36.7 43.3 41.9 47.7 41.9 43.3
NHB: Non-Hispanic Black, NHW: Non-Hispanic White, HW: Hispanic White, PMA: post mestrual age, BPD: bromchopulmonary dysplasia, CPAP: continuous positive airway
pressure, NICU: neonatal intensive care unit,
*Expired.
doi:10.1371/journal.pone.0025959.t001
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quantitative PCR (qPCR) assay described by Nadkarni [16]. Each
DNA sample was assayed in triplicate, and assays with coefficient
of variation (standard deviation/mean) greater than 20% were
repeated. We have validated the reproducibility of this assay in
comparable airway samples from children with cystic fibrosis [17].
Copy number was established using a standard curve assembled
from 10-fold serial dilutions of plasmid DNA containing a cloned
rRNA gene.
DNA sequencing was performed using barcoded primers (27F–
338R) compatible with the Roche 454 pyrosequenceras previ-
ously reported [18]. Each DNA was amplified in triplicate PCR
assays, which were pooled prior to assessing the product by
agarose gel electrophoresis. A negative control was run for each
barcode in parallel. Any assays where the negative control was
positive were repeated. Amplicons of the correct length were
arrayed in 96-well format for normalization. Amplicon concen-
tration was normalized using the SequalPrep normalization plate
(Invitrogen) prior to mixing [19]. Equal volumes were mixed,
concentrated by evaporation and gel purified using the Montage
Gel Purification Kit (Millipore). The resulting amplicon pool was
sequenced per manufacturer’s instructions using the Roche
Genome Sequencer FLX system at the Consortium for
Comparative Genomics sequencing facility at the University of
Colorado Denver.
Sequence analysis
Sequence data (fasta and quality files) were assigned to samples
by bar code and screened for low level quality defects (short
sequences ,150 nt in length, .1 sequence ambiguity, best read
with quality $20 over a 10 nt moving window) by the software
program BARTAB [20]. Non-bacterial sequences were removed
from the dataset by requiring a close match with a bacterial
secondary structure rRNA model within Infernal [21]. Sequences
identified as potential chimeras by ChimeraSlayer [22] were also
removed from the dataset. Taxonomic assignment was done by
the Ribosomal Database Project Classifier software [23]. We used
a BLAST database containing bacterial isolates identified in the
Silva ARB database (version 104) to assign species names [24].
The taxonomic information was used to construct sequence groups
with identical taxonomic rank, which were used to calculate
ecology statistics for each sample. Shannon diversity and Chao1
were computed, using rarefaction (100 replicates) to compensate
for differences in number of sequences per sample, using the
biodiv functionality contained within the XplorSeq Toolkit
[25,26].
Statistical analysis
Data were presented graphically, and descriptive statistics were
calculated using SAS v 9.2 (Cary, NC). The percent of total
sequence count was calculated for each individual organism.
Multilevel plots were constructed, displaying the percent of total
sequences, clinical culture results, and antibiotic courses for each
infant. Bacterial load and Shannon diversity index were plotted
individually for each patient. Formal statistical testing was not
performed.
Results
Of 49 subjects enrolled in the larger observational cohort at the
time of analysis, 10 patients met the ventilation and sampling
criteria for inclusion in this study. Clinical characteristics of the 10
patients are listed in Table 1. Patient 1 died at day of life 40 from
methicillin-resistant Staphylococcus aureus sepsis; this patient did not
have an autopsy performed. The remaining patients were all
diagnosed with BPD, ranging from mild to severe. All patients
received broad spectrum antibiotics, empirically or for confirmed
infection, at some point during the first 21 days of life (Figure 1).
The average yield of DNA from each sample was 32.9 ng/ml
(range: 0.4–143.6). A total of 107,487 sequences were analyzed,
with an average number of 3,359 (range: 1,724–4,915) per sample.
Only 4 of 10 samples collected ,72 hours of life had detectable
bacterial signal by qPCR to assess bacterial load. Further, only 2 of
these samples contained adequate load for successful sequence
analysis of the bacterial community. All samples collected from
day 7–21 of life contained detectable bacterial load (.70 copies/
reaction), and each sample was successfully amplified for bacterial
identification. The distribution of bacterial loads by day of
collection for each subject is shown in Figure 2A. Seventy-two
organisms were observed in total. The average number of
organisms identified per sample was 7 (range 2–23). Sequences
observed $1.0% of total in a sample represent 19organisms
(96.5% of total sequences; 1–9 organisms per sample). Chao1,a
nonparametric estimate of actual species richness in a sample,
predicted on average, 8 organisms in each sample (range 1–46).
The diversity of organisms in samples, determined by the Shannon
Index, is displayed by day of collection for each subject in
Figure 2B.
A dominant organism, defined as an organism representing
.50% of total sequences was identified in31 of 32 samples with
positive sequences(7 organisms represented). A dominant organism
represented .90% of total sequences in 13 samples (6 organisms).
Distributions of bacterial sequences in the samples for each patient
are displayed in Figure 1 along with results of clinically obtained
cultures and the timing of antibiotic administration. Ureaplasma-
parvum was the dominant organism in the two positive samples
from ,72 hours, one of which was from a subject exposed to
chorioamnionitis (subject 4). Ureaplasmaparvum or Ureaplasmaurealy-
ticum represented the dominant organism in 9 samples from 6
subjects, 5 samples of which were from subjects without evidence
of Ureaplasma on the initial sample. Staphylococcus species represent-
ed the dominant organism in 19 samples (17 were coagulase
negative Staphylococcus). Of these, Staphylococcus represented.90%
of sequences in7 samples. Staphylococcus aureus was the dominant
species in 2 samples (both collected on day 21). Pseudomonasaer-
uginosa (1 sample; day 14), Enterococcus faecalis (1 sample; day 21),
and Escherichia coli (1 sample; day 21) were the other dominant
organisms identified in samples.
Based on suspected lung infection by the physicians managing
these patients during the course of the study, 19 additional tracheal
aspirate samples were obtained for bacterial culture within at least
72 hours of research tracheal aspirate collections (Figure 1). Of
these, 14 (74%) had positive bacterial growth, with specific
Figure 1. Bacterial Composition of Tracheal Aspirate Samples for Each Patient by Day of Collection. Bacterial composition of each
sample is displayed in the bar graphs as a percent of total sequences in the sample. Each species can be identified by color according to the legend.
Days of antibiotic administration are displayed on the top of each graph with the solid lines depictingthe duration of specific antibiotic use as noted
on right side of the figure. Results of clinically obtained cultures are displayed in the middle section of each graph with an ‘‘x’’ depicting the day they
were obtained. All cultures were from tracheal aspirates unless otherwise noted. (NG: no growth, MURF: mixed upper respiratory flora, E. cloacae:
Enterobacter cloacae, K. pneumoniae: Klebsiella pneumonia, MSSA: methicillin sensitive Staphylococcal aureus, P. aeruginosa: Pseudomonas
aeruginosa.
doi:10.1371/journal.pone.0025959.g001
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flora (MURF)’’ reported in the remaining 3 samples. Sequencing
identified all bacteria that grew in the clinically indicated cultures
(n=11 positive cultures). Six of these 11 cultures grew 2 organisms,
however, the bacteria identified by culture did not always represent
the organisms with the most sequences identified by molecular
methods (n=5 cultures). Non-cultivatable bacteria, such as
Ureaplasma, were a significant source of discrepancies between the
molecular strategies versus standard culture approaches.
Potential pathogens identified by sequencing that were not
identified by culture include Ureaplasma (3 cultures), Pseudomonas (1
culture), and E. coli (1culture). Of the 5 samples that were obtained
for clinical indications that had no bacterial growth, the paired
research samples revealed Staphylococcus species as the dominant
organism in 3 samples, Ureaplasma species as the dominant
organism in one sample, and no bacterial amplification in the
remaining sample. Systemic antibiotics were administered for
some period of time during the first 21 days of life in all patients.
The median duration of antibiotic administration was 12 days
(range, 2–21). The median duration on 2 or more antibiotics was
10 days (range, 2–19). All samples collected after 72 hours of life
that had Ureaplasma species as the dominant organism (n=7) had
been treated with 2 or more antibiotics in the interval between
research samples.
Discussion
We performed molecular identification of bacteria in serial
tracheal aspirate samples from intubated preterm infants by
isolating rRNA genes harvested by PCR to determine the
composition of bacterial communities and the timing of acquisition
in the airways of these infants. We found that during the first
72 hours after birth, the majority of tracheal aspirate samples had
low or undetectable bacterial loads. However, within 7 days of life,
sustained bacterial colonization with diverse species is present in
the airways of intubated preterm infants. 96.9% of samples with
bacterial detection exhibited a dominant organism, with Staphylo-
coccus and Ureaplasma species most frequently identified as the
dominant organisms. Molecular methods identified all species
detected by traditional clinical cultures, but also identified
potential pathogens, including Ureaplasma, that were not detected
by standard bacterial culture methods. Thus, improved resolution
of bacterial detection with regard to overall bacterial load, species
diversity within the microbiome or the identification of specific
organisms for directed therapy, has the potential to yield further
insights into the pathogenesis of BPD and late respiratory
outcomes of preterm newborns.
These findings are important because early respiratory infection
and inflammation have been shown to impair alveolar develop-
ment [27] and contribute to the development of BPD [28].
Inflammatory injury disrupts lung growth in part by production of
pro-inflammatory cytokines [29]. Although pro-inflammatory
cytokines have been associated with the development of BPD
and adverse outcomes [30,31,32], variable assessments of the pro-
inflammatory response, and lack of context specificity (identifica-
tion of all aspects of the perinatal milieu contributing to disease)
have precluded the use of cytokines as adequate biomarkers for
BPD. While antenatal and postnatal infections, hyperoxia, and
mechanical ventilation have garnered much attention as inflam-
mation provoking stimuli, the possible impact of airway coloni-
zation on the development of BPD is less clear and has generated
contradictory results [33]. The presence of Ureaplasma in the
respiratory tract of preterm infants, even without signs of infection,
has been associated with a pro-inflammatory response and an
increased risk for BPD [34]. Although earlier trials of erythromy-
cin treatment for the treatment of Ureaplasma in preterm infants
failed to show benefit [35,36,37,38], a recent trial of azithromycin
treatment revealed a significant reduction in the endpoint of BPD
or death in the subgroup of patients who were found to be
colonized or infected with Ureaplasma [39]. Thus, Ureaplasma
remains a plausible but still unconfirmed contributor to BPD.
Ureaplasma was the dominant organism in at least one sample for 6
of the 10 infants in our study. Ureaplasma was found to be the
Figure 2. Comparison of Bacterial Load and Shannon Diversity
Index by Age. A. Distribution of total bacterial loads by sample. Lines
connect samples from each patient, labeled with the patient number
corresponding to clinical data presented in Table 1. B. Diversity of
organisms by sample as determined by the Shannon Index. Lines
connect samples from each patient, labeled with the patient number
corresponding to clinical data presented in Table 1.
doi:10.1371/journal.pone.0025959.g002
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initial samples, suggesting the possibility of post-natal acquisition
and/or the presence of environmental factors, such as antibiotic
administration, that encourage selection of this genus. The
association between antibiotic administration, Ureaplasma coloni-
zation, and risk for BPD should be explored further in future
studies. Exposure to colonizing bacteria may impact the preterm
infant’s immune response and subsequent lung development.
Improved resolution of bacterial detection techniques as demon-
strated here in conjunction with assessments of inflammation could
improve our understanding of the developing host immune
response in premature infants and its relationship to pathogen
exposure.
Molecular methods have contradicted the traditional theory
that human lower airways are sterile by demonstrating that the
lungs of healthy older children and adults are rich with microbial
flora [9,10], and that traditional culture methods are not
adequate to investigate the contribution of microbial communi-
ties to disease. Our results, together with a previous report [40]
suggest that microbial communities are present early in the lower
airways of intubated preterm infants. Rapidly accumulating
evidence demonstrates that microbial communities play an
important role in human physiology [41,42]. Several diseases
have been associated with changes in composition and diversity
of these microbial communities [43,44,45]. Some have shown
that microbiota of limited diversity and relative absence of
commensal organisms are associated with increased inflamma-
tion, barrier permeability, and disease status [46,47]. Early
evaluations of the respiratory tract microbiota in pulmonary
diseases such as cystic fibrosis, asthma, and COPD [9,10] also
reveal shifts in microbial composition compared to healthy
patients, suggesting the composition of the respiratory tract
microbiota can play a direct role in pathophysiology of lung
disease. Neonatal oropharyngeal colonization with Streptococcus
pneumoniae, Moraxella catarrhalis, Haemophilusinfluenzae,o rac o m b i -
nation of these organisms, but not colonization with Staphylo-
coccusaureus, was significantly associated with persistent wheeze in
childhood [8]. Children living on farms are exposed to a wider
range of microbes than were children living in urban
environments, and these children appear relatively protected
from asthma and atopy [48]. Together, these studies suggest the
respiratory tract microbiota early in life can also modulate the
host immune response and future lung disease.
Only 2of 10 samples collected within 72 hours after birth
exhibited sufficient bacterial load for sequence analysis, suggesting
the lower airways of preterm infants typically have comparatively
low bacterial loads. One of these two samples was obtained from
an infant exposed to chorioamnionitis and revealed Ureaplasma-
parvum, a known cause of chorioamnionitis, as the dominant
organism. Although a diverse array of bacteria were detected
within the samples of these 10 infants, the diversity of organisms
within samples was far less than detected in respiratory samples of
older children and adults [9,10]. Further, bacterial diversity was
not associated with age of the infant or BPD severity.
The use of antibiotics administered to treat confirmed or
potential infections may have long term effects on the
composition of the airway microbial community. Potential
negative consequences include the elimination of commensal
bacteria and selection for other pathogenic bacteria, especially
those that are not readily detected by clinical culture techniques
and that promote chronic airway inflammation. Further studies
will need to investigate the potential role of antibiotics on the
composition of the airway microbiota and the impact on early
lung development.
There are several limitations to our study. First, the small
sample size in this pilot study precludes rigorous evaluation of
the presence of specific bacteria, bacterial loads, or species
diversity to the risk of BPD. All of the infants included in this
study were less than 28 weeks gestation and required mechanical
ventilation for at least 21 days, which represents a very high risk
population for severe BPD. Serial evaluation of the airway
microbiome in preterm infants who do not develop BPD will be
important to determine how the composition of the airway
microbiome is related to risk of BPD. Since preterm infants who
do not develop BPD often do not require long periods of
mechanical ventilation support, noninvasive methods of airway
sampling will be required. Second, all infants in this study were
treated with systemic antibiotics which are likely to impact the
evolution of microbial composition, limiting the ability to
ascertain the natural acquisition of airway colonization after
birth. The presence of endotracheal tubes also impacts the
access of microbes to lower airways. Although we attempted to
compare molecular detection methods to clinical culture results,
the samples were not simultaneously obtained. Therefore, the
discrepancies between the two results cannot be accounted for
by methodology alone. In addition, sampling of tracheal
aspirates may not adequately reflect bacterial exposure at the
alveolar level. Simultaneous sampling of the upper airway, lower
airways and alveolar samples are required to provide a more
complete assessment of bacterial colonization. Finally, future
studies are needed to more directly link the presence of specific
airway organisms, airway bacterial load, and diversity of the
microbiota with altered innate immunity and inflammatory
cytokines to better understand how early colonization impacts
lung inflammation.
In summary, early bacterial colonization with diverse species
are present in the airways of intubated preterm infants, and can
be characterized by bacterial load and species diversity.
Molecular detection of Ureaplasma species in the airways of
preterm infants late in the course of mechanical ventilation
provides further support for the concept that Ureaplasma may be
involved in the pathogenesis of BPD and requires further
investigation. Molecular identification of bacteria in the lower
airways of preterm infants has the potential to yield further
insight into the pathogenesis of BPD and to identify novel
therapeutic targets.
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